Hat mitgewirkt an:
-
Genome-wide epigenomic analyses of cell-free DNA from anaplastic lymphoma kinase-rearranged non-small cell lung cancer patients
-
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
-
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA